News

Taboola Expands Share Repurchase Program by $200 Million

Taboola Expands Share Repurchase Program by $200 Million

Taboola Expands Share Repurchase Program

Taboola, a global pioneer in performance advertising technology, has made headlines with its recent announcement regarding an additional share repurchase authorization amounting to $200 million. This decision, approved by the company’s Board of Directors, brings the total authorized share repurchase to roughly $240 million, a move showcasing the company's strong financial health and commitment to shareholder value.

Confidence in Financial Performance

Steve Walker, the CFO of Taboola, expressed enthusiasm about this expansion, emphasizing the company's robust performance in previous quarters. He stated, “Driven by our confidence in the business and our ability to generate strong free cash flow, we are pleased to announce a substantial expansion to our existing share repurchase authorization.” This statement reflects Taboola's aim to maintain positive momentum while strategically investing in long-term growth opportunities.

Details of the Share Buyback Program

Under this program, Taboola may execute share purchases intermittently on the open market. The buybacks can occur through trading plans designed to comply with Rule 10b5-1 under the Securities Exchange Act of 1934, through privately negotiated transactions, or via other means. The execution of the buyback will depend on market conditions and various factors that the company will evaluate. It's worth noting that Taboola retains the right to modify, suspend, or discontinue the program at any point, underscoring its agile approach in managing shareholder resources.

Investor Day Announcement

Looking ahead, Taboola has scheduled an Investor Day, intended for engagement and clarity regarding the company's future strategies. This event is set to take place on March 26, in a vibrant location. During the event, members of Taboola's management team will delve into key topics such as the company’s strategic direction, market opportunities, and financial outlook. It promises to be an informative session, catering to both existing and prospective investors eager to understand more about Taboola's ambitious plans.

What to Expect at the Investor Day

At the upcoming Investor Day, participants can look forward to detailed insights from management and guest speakers regarding the company's strategic initiatives. The event will begin promptly at 10:00 a.m. ET and is expected to conclude around 1:00 p.m. ET. A live video webcast along with a slide presentation will be available on Taboola's investor relations website, ensuring that those who cannot attend in person can still engage with the content shared during the event.

Understanding Taboola's Unique Market Position

Taboola has carved out a significant niche in the advertising technology landscape. By working with a diverse array of businesses, Taboola leverages its advertising platform, Realize, to connect advertisers with around 600 million daily active users. Publishers such as NBC News and Yahoo have integrated Taboola’s technology to enhance audience engagement and revenue generation, solidifying the company’s pivotal role in digital marketing.

About Taboola

At its core, Taboola is dedicated to empowering businesses through innovative advertising solutions that extend beyond conventional avenues like search and social networks. By delivering measurable outcomes at scale, Taboola helps advertisers navigate the complex landscape of digital marketing, ensuring that they achieve their business objectives effectively and efficiently.

Investor and Press Contacts

For investor inquiries, Taboola's team includes Jessica Kourakos and Aadam Anwar, who can be reached via email for more information about the company's performance and strategic initiatives. The press contact for Taboola is Dave Struzzi, offering media representatives a point of contact for news related to the company's developments.

Frequently Asked Questions

What is Taboola's recent share repurchase announcement about?

Taboola announced an expansion of its share repurchase program by an additional $200 million, increasing the total authorization to around $240 million.

Who is the CFO of Taboola?

The CFO of Taboola is Steve Walker, who highlighted the company's confidence in its strong financial performance.

When is Taboola's upcoming Investor Day?

Taboola's Investor Day is scheduled for March 26, providing insights into its strategy, market potential, and financial outlook.

What audience can Taboola reach through its advertising platform?

Taboola can reach approximately 600 million daily active users through its ad platform, Realize.

How can investors get in touch with Taboola?

Investors can contact Taboola's investor relations team via the email address provided for inquiries regarding company performance and initiatives.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Ensign Group Faces Class Action Amid Stock Plummet

Updated Category News Views 117

Ensign Group's Recent Troubles Unraveled Let's set the scene: Ensign Group, once riding high at over $170 a share, finds itself knee-deep in allegations that'll make any investor squirm. Now, we're not just talking about a typical market fluctuation here – this is a real smackdown with an 8.2% drop, all thanks to some damning accusations. A Closer Look at Allegations...

Continue Reading
Sirolimus-Coated Balloon Shows Promise in TRANSFORM II

Updated Category News Views 96

Breaking Down the TRANSFORM II Trial Innovation never rests, folks, especially when it comes to treating coronary artery disease. Right on cue, the TRANSFORM II trial's results have hit the airwaves, marking a significant milestone with its implant-free MagicTouch Sirolimus-Coated Balloon (SCB) strategy. Getting the Lay of the Land This wasn't just some backyard...

Continue Reading
ElektraFi Challenges Starlink: Fixed Wireless Gains Edge

Updated Category News Views 93

Revolution or Just Better Options? In the wild west of internet connectivity, where every home is a frontier, ElektraFi is throwing down the gauntlet at the feet of behemoths like Starlink. They're talking big about their fixed wireless network, and in places stretching from Colorado's ski slopes to the dustier reaches of Texas, that talk might just hold some weight. Why...

Continue Reading
IntelliGenome Partners with NL Diagnóstica for TB Battle

Updated Category News Views 127

Breaking New Ground in Tuberculosis Detection When IntelliGenome, a Houston-based developer of CRISPR-based diagnostic tech, teams up with São Paulo's veteran player NL Diagnóstica, you know they're onto something game-changing. This partnership is all about taking the fight against tuberculosis in Brazil to new heights with their CRISPR-Dx™ diagnostic platform. Not...

Continue Reading
Curaleaf Takes Stake in NJ's Boone Town Dispensary

Updated Category News Views 140

Curaleaf's Bold Move in the Garden State Curaleaf Holdings, Inc. is doubling down on its cannabis bet in New Jersey. The acquisition of an equity stake in Boone Town Provisions, located at 677 Myrtle Ave., Boonton, NJ, boosts Curaleaf’s dispensary count to four in the state. The company's not just wandering on the map; it's pinpointing high-performing locations to...

Continue Reading
Downsizing Tips for Seniors: Start Early, Plan Smart

Updated Category News Views 55

When Change Means Home: Addressing Downsizing Head-On It ain't just about shrinking the square footage when longtime homeowners face the dreaded D-word: downsize. Senior folks around New Philadelphia, Ohio are sitting on an emotional and logistical minefield when it comes to shedding that family home. And who else stepped up to bat but local real estate duo Holly Abel...

Continue Reading
MetaOptics Expands U.S. Reach with ADR Programme

Updated Category News Views 123

A Bold Move into the U.S. Market MetaOptics Ltd, the semiconductor optics dynamo out of Singapore, is kicking up some investment dust with their American Depositary Receipts (ADR) Programme aimed squarely at expanding its U.S. footprint. And let me tell you, in the game of international market expansion, that's no rookie maneuver. Why ADR? Why Now? So, why is MetaOptics...

Continue Reading
Illumina's Role in Singapore's Precision Medicine Leap

Updated Category News Views 24

Singapore's Bold Step into Precision Medicine When it comes to revolutionizing healthcare, Singapore isn't content to sit on the sidelines. They've just thrown a serious hat into the ring with the SG-INSIGHT study, a cornerstone of their National Precision Medicine programme. And Illumina, Inc. (NASDAQ:ILMN) is right there in it, gearing up to sequence the genomes of...

Continue Reading
EASE Unlocks $9.5M for AI Medical Expansion in Africa

Updated Category News Views 141

Transforming Healthcare in South Africa and Ghana Expanding into uncharted territories often requires a leap of faith, and EASE Holdings has just taken a substantial one. The medical equipment-as-a-service provider has grabbed a hefty $9.5 million in equity from AAFC Group Inc. The goal? To flood South Africa and Ghana with cutting-edge medical imaging and surgical...

Continue Reading
Hudsonville's Leadership Shift Eyes the Future

Updated Category News Views 147

Hudsonville's New Chapter: Enter CJ Ellens When a firm as storied as Hudsonville Ice Cream elects a new captain at the helm, folks sit up and take notice. CJ Ellens, already well-embedded in the fabric of Hudsonville, is set to steer the ship starting January 1, 2027. This isn't just a revolving door of C-suites, but more like a passing of the torch to someone bred in the...

Continue Reading

Top 5 Most Recently Viewed Articles

Innovative Pool Trends Reshaping Backyard Experiences in 2025

Updated Category News Views 155

Transforming Outdoor Spaces: Latham's Insights on Pool Trends As the pool industry progresses into a new era, homeowners are increasingly drawn to trendy designs and advanced technologies that redefine how swimming pools are perceived and used. The latest innovations are centered around increasing efficiency, enhancing aesthetics, and incorporating luxurious features into...

Continue Reading
National Grid Renewables Partners with Microsoft for Solar Power

Updated Category News Views 100

National Grid Renewables Partners with Microsoft for Solar Power National Grid Renewables has recently completed a significant power purchase agreement (PPA) with Microsoft for its new 250-megawatt (MW) solar project. This initiative promises to harness clean energy while contributing positively to local economies. Investing in Solar Energy for a Sustainable Future The...

Continue Reading
Legal Action Against Iovance Biotherapeutics: Essential Insights

Updated Category News Views 141

Understanding the Recent Legal Developments for Iovance Biotherapeutics In recent news, a notable lawsuit has been filed involving Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), which has raised concerns among its investors. This legal action is significant, as it addresses potential violations of federal securities laws by the biopharmaceutical company and its senior...

Continue Reading
Understanding the P/E Ratio for NetEase's Future Growth

Updated Category News Views 163

Decoding NetEase's P/E Ratio In the current trading session, NetEase Inc. NTES shares are priced at $132.28, reflecting a slight decline of 1.94%. Over the past month, the stock has faced a small decrease of 0.68%. However, on an annual scale, the stock has impressively increased by 47.12%. Investors observing short-term fluctuations may find themselves questioning the...

Continue Reading
IMAX Breaks Records with $53 Million During Chinese New Year

Updated Category News Views 166

IMAX Breaks Records During the Chinese New Year Celebration IMAX Corporation (NYSE: IMAX) has made headlines by achieving an unprecedented box office milestone during the Chinese New Year, raking in an impressive $53 million over the holiday period that concluded recently. This surpasses their previous record of $34 million set just a year prior, marking a staggering 57%...

Continue Reading